Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
| Previous close | 132.60 |
| Open | 131.88 |
| Bid | 132.56 x N/A |
| Ask | 132.60 x N/A |
| Day's range | 131.88 - 134.20 |
| 52-week range | 101.36 - 159.32 |
| Volume | |
| Avg. volume | 2,459,312 |
| Market cap | 109.25B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 54.33 |
| EPS (TTM) | 2.44 |
| Earnings date | N/A |
| Forward dividend & yield | 0.20 (0.15%) |
| Ex-dividend date | 03 July 2023 |
| 1y target est | 153.75 |
PR NewswireUnited Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility, internal governance, and sustainability.
PR NewswireUnited Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023, marking a stable increase of 23.52%. Net income attributable to the shareholders of the parent company was 1.97 billion CNY, reflecting a YoY increase of 19.21 %.
PR NewswireUnited Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023
United Imaging Healthcare (SSE:688271), a global innovator in cutting-edge medical imaging and radiotherapy equipment, has unveiled its highly anticipated 2023 half-year report, revealing robust growth. The report indicates that the company achieved 5.27 billion CNY in revenue during H1 2023, marking a significant 26.35% YoY increase. Net income attributable to the shareholders reached 0.94 billion CNY, reflecting a YoY increase of 21.19%.
